Molecular classification improves preoperative risk assessment of endometrial cancer

被引:4
作者
Cabrera, Silvia [1 ]
Bebia, Vicente [1 ]
Lopez-Gil, Carlos [2 ]
Luzarraga-Aznar, Ana [1 ]
Denizli, Melek [2 ]
Salazar-Huayna, Lourdes [3 ]
Abdessayed, Nihed [4 ]
Castellvi, Josep [3 ]
Colas, Eva [2 ]
Gil-Moreno, Antonio [1 ]
机构
[1] Univ Autonoma Barcelona UAB, Vall dHebron Univ Hosp, Gynecol Dept, Gynecol Oncol Unit, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain
[2] Univ Autonoma Barcelona UAB, Vall Hebron Inst Res Hosp, Grp Biomed Res Gynecol, CIBERONC, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain
[3] Vall dHebron Univ Hosp, Pathol Dept, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain
[4] Farhat Hached Univ Hosp, Pathol Dept, Sousse, Tunisia
关键词
Endometrial cancer; Molecular classification; Preoperative assessment; Surgery; Extrauterine disease; LYMPH-NODE METASTASIS; TRANSVAGINAL ULTRASOUND; MYOMETRIAL INVASION; CARCINOMA; SPECIMENS;
D O I
10.1016/j.ygyno.2024.07.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. We aimed to evaluate the performance of endometrial cancer (EC) molecular classification in predicting extrauterine disease after primary surgery alone and in combination with other clinical data available in preoperative setting. Methods. Retrospective single-center observational study including patients with endometrial adenocarcinoma treated with primary surgery between December 1994 and May 2022. Molecular profiling was performed using immunohistochemistry of p53, MLH1, PMS2, MSH2 and MSH6; and KASP genotyping of the 6 most common mutations of POLE gene. Clinical, pathological and imaging information was reviewed. Logistic regression, regression trees and random forest classification techniques (CART) were performed. Results. We enrolled 658 patients, 47 with POLEmut (7.1%), 234 with MMRd (35.6%), 95 with p53abn (14.4%) and 282 with NSMP (42.8%) tumors. Advanced stage after primary surgery (III-IV FIGO 2009) was diagnosed in 11.7% of patients, p53abn tumors showed increased extrauterine spread (34.1%) and nodal involvement (30.1%) (p < .001). In multivariate analysis, only p53abn subgroup (aOR = 16.0, CI95% = 1.5-165.1) and radiological suspicion of extrauterine disease (aOR = 24.2, CI95% = 12.2-48.2) independently predicted the finding of extrauterine disease after primary surgery. In patients with preoperative uterine-confined disease, deep myometrial and cervical involvement in radiological assessment and p53abn molecular subtype were the best variables to identify patients at-risk of occult extrauterine disease after the staging surgery. Conclusion. EC molecular classification is more accurate than histotype or grade in preoperative biopsy to predict advanced disease, and together with imaging tests are the most reliable preoperative information. This work provides an initial framework for using molecular information preoperatively to tailor surgical treatment. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:56 / 63
页数:8
相关论文
共 30 条
  • [1] Transvaginal ultrasound for preoperative assessment of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis
    Alcazar, J. L.
    Orozco, R.
    Corral, T. Martinez-Astorquiza
    Juez, L.
    Utrilla-Layna, J.
    Minguez, J. A.
    Jurado, M.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2015, 46 (04) : 405 - 413
  • [2] Board WC of TE, 2024, Female Genital Tumours
  • [3] Are preoperative histology and MRI useful for classification of endometrial cancer risk?
    Body, Noemie
    Lavoue, Vincent
    De Kerdaniel, Olivier
    Foucher, Fabrice
    Henno, Sebastien
    Cauchois, Aurelie
    Laviolle, Bruno
    Leblanc, Marc
    Leveque, Jean
    [J]. BMC CANCER, 2016, 16
  • [4] Clinical Utility of Preoperative Computed Tomography in Patients With Endometrial Cancer
    Bogani, Giorgio
    Gostout, Bobbie S.
    Dowdy, Sean C.
    Multinu, Francesco
    Casarin, Jvan
    Cliby, William A.
    Frigerio, Luigi
    Kim, Bohyun
    Weaver, Amy L.
    Glaser, Gretchen E.
    Mariani, Andrea
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (08) : 1685 - 1693
  • [5] Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program
    Bosse, T.
    Creutzberg, C. L.
    Crosbie, E. J.
    Han, K.
    Horeweg, N.
    Leary, A.
    Kroep, J. R.
    McAlpine, J. N.
    Powell, M. E.
    Blanc-Durand, F.
    de Bruyn, M.
    Church, D. N.
    Koelzer, V. H.
    Kommoss, S.
    Singh, N.
    Bardet, A.
    Counsell, N.
    Putter, H.
    Tu, D.
    Edmondson, R.
    Gordon, C.
    Ledermann, J.
    Morice, P.
    MacKay, H.
    Nijman, H.
    Nout, R. A.
    Smit, V. T. H. B. M.
    White, H.
    Alexandre, J.
    de Boer, S. M.
    Boere, I
    Cooper, R.
    Ethier, J. L.
    Frenel, J. S.
    McGrane, J.
    Taylor, A.
    Welch, S.
    Westermann, A. M.
    Dijcker-van der Linden, H.
    Farrelly, L.
    Feeney, A.
    Kaya, M.
    Liu, W.
    Melis, A.
    Ngadjeua-Tchouatieu, F.
    Parulekar, W.
    Verhoeven-Adema, K.
    RAINBO Res Consortium
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (01) : 109 - 117
  • [6] Efficacy of transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial invasion in patients with endometrioid endometrial cancer: a prospective comparative study
    Cerovac, Anis
    Ljuca, Dzenita
    Arnautalic, Lejla
    Habek, Dubravko
    Bogdanovic, Gordana
    Mustedanagic-Mujanovic, Jasminka
    Grgic, Gordana
    [J]. RADIOLOGY AND ONCOLOGY, 2022, 56 (01) : 37 - 45
  • [7] ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
    Concin, Nicole
    Matias-Guiu, Xavier
    Vergote, Ignace
    Cibula, David
    Mirza, Mansoor Raza
    Marnitz, Simone
    Ledermann, Jonathan
    Bosse, Tjalling
    Chargari, Cyrus
    Fagotti, Anna
    Fotopoulou, Christina
    Gonzalez Martin, Antonio
    Lax, Sigurd
    Lorusso, Domenica
    Marth, Christian
    Morice, Philippe
    Nout, Remi A.
    O'Donnell, Dearbhaile
    Querleu, Denis
    Raspollini, Maria Rosaria
    Sehouli, Jalid
    Sturdza, Alina
    Taylor, Alexandra
    Westermann, Anneke
    Wimberger, Pauline
    Colombo, Nicoletta
    Planchamp, Francois
    Creutzberg, Carien L.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (01) : 12 - 39
  • [8] Impact and cost of preoperative computed tomography imaging on the management of patients diagnosed with high-grade endometrial cancer
    Dai, Serina
    Nahas, Samar
    Murphy, Joan K.
    Lawrence, Janet
    May, Taymaa
    Feigenberg, Tomer
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 145 (02) : 219 - 224
  • [9] Integrated genomic characterization of endometrial carcinoma
    Getz, Gad
    Gabriel, Stacey B.
    Cibulskis, Kristian
    Lander, Eric
    Sivachenko, Andrey
    Sougnez, Carrie
    Lawrence, Mike
    Kandoth, Cyriac
    Dooling, David
    Fulton, Robert
    Fulton, Lucinda
    Kalicki-Veizer, Joelle
    McLellan, Michael D.
    O'Laughlin, Michelle
    Schmidt, Heather
    Wilson, Richard K.
    Ye, Kai
    Ding, Li
    Mardis, Elaine R.
    Ally, Adrian
    Balasundaram, Miruna
    Birol, Inanc
    Butterfield, Yaron S. N.
    Carlsen, Rebecca
    Carter, Candace
    Chu, Andy
    Chuah, Eric
    Chun, Hye-Jung E.
    Dhalla, Noreen
    Guin, Ranabir
    Hirst, Carrie
    Holt, Robert A.
    Jones, Steven J. M.
    Lee, Darlene
    Li, Haiyan I.
    Marra, Marco A.
    Mayo, Michael
    Moore, Richard A.
    Mungall, Andrew J.
    Plettner, Patrick
    Schein, Jacqueline E.
    Sipahimalani, Payal
    Tam, Angela
    Varhol, Richard J.
    Robertson, A. Gordon
    Pashtan, Itai
    Saksena, Gordon
    Onofrio, Robert C.
    Schumacher, Steven E.
    Tabak, Barbara
    [J]. NATURE, 2013, 497 (7447) : 67 - 73
  • [10] Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases
    Jamieson, Amy
    Thompson, Emily F.
    Huvila, Jutta
    Leung, Samuel
    Lum, Amy
    Morin, Chantale
    Ennour-Idrissi, Kaoutar
    Sebastianelli, Alexandra
    Renaud, Marie-Claude
    Gregoire, Jean
    Huntsman, David G.
    Gilks, C. Blake
    Plante, Marie
    Grondin, Katherine
    McAlpine, Jessica N.
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 165 (02) : 376 - 384